Pyxis Oncology

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$2,820
$0
$3,402
$0
Gross Profit
2,820
-552
1,701
-731
EBITDA
-19,215
-22,914
-18,555
-23,023
EBIT
-19,750
-23,466
-19,105
-23,754
Net Income
-18,354
-21,158
-35,571
-21,203
Net Change In Cash
2,820
0
3,402
0
Free Cash Flow
-17,263
-22,535
-19,290
-14,665
Cash
10,733
12,759
19,473
12,056
Basic Shares
61,918
61,048
60,715
60,715

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$16,146
$0
$0
$0
Gross Profit
15,671
-2,000
-1,836
-1,251
EBITDA
-65,514
-78,493
-122,772
-69,070
EBIT
-68,496
-80,493
-123,481
-70,321
Net Income
-77,331
-73,790
-117,953
-81,536
Net Change In Cash
16,146
0
0
0
Cost of Revenue
-95,551
268,128
Free Cash Flow
-57,909
-77,435
-95,734
-35,866
Cash
19,473
9,664
179,293
274,735
Basic Shares
58,445
39,904
33,033
32,222

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.30
2025-03-31
-$0.35
2024-12-31
-$1.32